Global Epilepsy Drugs Market Insights and Forecast to 2028

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

Market Analysis and Insights: Global Epilepsy Drugs Market

The global Epilepsy Drugs market size is projected to reach US$ 5842.4 million by 2028, from US$ 4769.1 million in 2021, at a CAGR of 2.9% during 2022-2028.

In terms of geography, the Americas led the global epilepsy drugs market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy Drugs market.

Global Epilepsy Drugs Scope and Market Size

Epilepsy Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Epilepsy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

First Generation

Second Generation

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Abbott Laboratories

GlaxoSmithKline Plc

UCB

Cephalon

Johnson & Johnson

Pfizer

Novartis AG

Abbvie

Janssen Pharmaceuticals

Sunovion Pharmaceuticals

Bausch Health

Sanofi S.A

Takeda

Eisai

F. Hoffmann-La Roche

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Epilepsy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 First Generation

1.2.3 Second Generation

1.3 Market by Application

1.3.1 Global Epilepsy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

2.1 Global Epilepsy Drugs Market Perspective (2017-2028)

2.2 Epilepsy Drugs Growth Trends by Region

2.2.1 Epilepsy Drugs Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Epilepsy Drugs Historic Market Size by Region (2017-2022)

2.2.3 Epilepsy Drugs Forecasted Market Size by Region (2023-2028)

2.3 Epilepsy Drugs Market Dynamics

2.3.1 Epilepsy Drugs Industry Trends

2.3.2 Epilepsy Drugs Market Drivers

2.3.3 Epilepsy Drugs Market Challenges

2.3.4 Epilepsy Drugs Market Restraints

3.1 Global Top Epilepsy Drugs Players by Revenue

3.1.1 Global Top Epilepsy Drugs Players by Revenue (2017-2022)

3.1.2 Global Epilepsy Drugs Revenue Market Share by Players (2017-2022)

3.2 Global Epilepsy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Epilepsy Drugs Revenue

3.4 Global Epilepsy Drugs Market Concentration Ratio

3.4.1 Global Epilepsy Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Drugs Revenue in 2021

3.5 Epilepsy Drugs Key Players Head office and Area Served

3.6 Key Players Epilepsy Drugs Product Solution and Service

3.7 Date of Enter into Epilepsy Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Epilepsy Drugs Historic Market Size by Type (2017-2022)

4.2 Global Epilepsy Drugs Forecasted Market Size by Type (2023-2028)

5.1 Global Epilepsy Drugs Historic Market Size by Application (2017-2022)

5.2 Global Epilepsy Drugs Forecasted Market Size by Application (2023-2028)

6.1 North America Epilepsy Drugs Market Size (2017-2028)

6.2 North America Epilepsy Drugs Market Size by Type

6.2.1 North America Epilepsy Drugs Market Size by Type (2017-2022)

6.2.2 North America Epilepsy Drugs Market Size by Type (2023-2028)

6.2.3 North America Epilepsy Drugs Market Share by Type (2017-2028)

6.3 North America Epilepsy Drugs Market Size by Application

6.3.1 North America Epilepsy Drugs Market Size by Application (2017-2022)

6.3.2 North America Epilepsy Drugs Market Size by Application (2023-2028)

6.3.3 North America Epilepsy Drugs Market Share by Application (2017-2028)

6.4 North America Epilepsy Drugs Market Size by Country

6.4.1 North America Epilepsy Drugs Market Size by Country (2017-2022)

6.4.2 North America Epilepsy Drugs Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7.1 Europe Epilepsy Drugs Market Size (2017-2028)

7.2 Europe Epilepsy Drugs Market Size by Type

7.2.1 Europe Epilepsy Drugs Market Size by Type (2017-2022)

7.2.2 Europe Epilepsy Drugs Market Size by Type (2023-2028)

7.2.3 Europe Epilepsy Drugs Market Share by Type (2017-2028)

7.3 Europe Epilepsy Drugs Market Size by Application

7.3.1 Europe Epilepsy Drugs Market Size by Application (2017-2022)

7.3.2 Europe Epilepsy Drugs Market Size by Application (2023-2028)

7.3.3 Europe Epilepsy Drugs Market Share by Application (2017-2028)

7.4 Europe Epilepsy Drugs Market Size by Country

7.4.1 Europe Epilepsy Drugs Market Size by Country (2017-2022)

7.4.2 Europe Epilepsy Drugs Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8.1 Asia-Pacific Epilepsy Drugs Market Size (2017-2028)

8.2 Asia-Pacific Epilepsy Drugs Market Size by Type

8.2.1 Asia-Pacific Epilepsy Drugs Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Epilepsy Drugs Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Epilepsy Drugs Market Share by Type (2017-2028)

8.3 Asia-Pacific Epilepsy Drugs Market Size by Application

8.3.1 Asia-Pacific Epilepsy Drugs Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Epilepsy Drugs Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Epilepsy Drugs Market Share by Application (2017-2028)

8.4 Asia-Pacific Epilepsy Drugs Market Size by Region

8.4.1 Asia-Pacific Epilepsy Drugs Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Epilepsy Drugs Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9.1 Latin America Epilepsy Drugs Market Size (2017-2028)

9.2 Latin America Epilepsy Drugs Market Size by Type

9.2.1 Latin America Epilepsy Drugs Market Size by Type (2017-2022)

9.2.2 Latin America Epilepsy Drugs Market Size by Type (2023-2028)

9.2.3 Latin America Epilepsy Drugs Market Share by Type (2017-2028)

9.3 Latin America Epilepsy Drugs Market Size by Application

9.3.1 Latin America Epilepsy Drugs Market Size by Application (2017-2022)

9.3.2 Latin America Epilepsy Drugs Market Size by Application (2023-2028)

9.3.3 Latin America Epilepsy Drugs Market Share by Application (2017-2028)

9.4 Latin America Epilepsy Drugs Market Size by Country

9.4.1 Latin America Epilepsy Drugs Market Size by Country (2017-2022)

9.4.2 Latin America Epilepsy Drugs Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10.1 Middle East & Africa Epilepsy Drugs Market Size (2017-2028)

10.2 Middle East & Africa Epilepsy Drugs Market Size by Type

10.2.1 Middle East & Africa Epilepsy Drugs Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Epilepsy Drugs Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Epilepsy Drugs Market Share by Type (2017-2028)

10.3 Middle East & Africa Epilepsy Drugs Market Size by Application

10.3.1 Middle East & Africa Epilepsy Drugs Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Epilepsy Drugs Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Epilepsy Drugs Market Share by Application (2017-2028)

10.4 Middle East & Africa Epilepsy Drugs Market Size by Country

10.4.1 Middle East & Africa Epilepsy Drugs Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Epilepsy Drugs Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Epilepsy Drugs Introduction

11.1.4 Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022)

11.1.5 Abbott Laboratories Recent Developments

11.2 GlaxoSmithKline Plc

11.2.1 GlaxoSmithKline Plc Company Details

11.2.2 GlaxoSmithKline Plc Business Overview

11.2.3 GlaxoSmithKline Plc Epilepsy Drugs Introduction

11.2.4 GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022)

11.2.5 GlaxoSmithKline Plc Recent Developments

11.3 UCB

11.3.1 UCB Company Details

11.3.2 UCB Business Overview

11.3.3 UCB Epilepsy Drugs Introduction

11.3.4 UCB Revenue in Epilepsy Drugs Business (2017-2022)

11.3.5 UCB Recent Developments

11.4 Cephalon

11.4.1 Cephalon Company Details

11.4.2 Cephalon Business Overview

11.4.3 Cephalon Epilepsy Drugs Introduction

11.4.4 Cephalon Revenue in Epilepsy Drugs Business (2017-2022)

11.4.5 Cephalon Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Epilepsy Drugs Introduction

11.5.4 Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022)

11.5.5 Johnson & Johnson Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Epilepsy Drugs Introduction

11.6.4 Pfizer Revenue in Epilepsy Drugs Business (2017-2022)

11.6.5 Pfizer Recent Developments

11.7 Novartis AG

11.7.1 Novartis AG Company Details

11.7.2 Novartis AG Business Overview

11.7.3 Novartis AG Epilepsy Drugs Introduction

11.7.4 Novartis AG Revenue in Epilepsy Drugs Business (2017-2022)

11.7.5 Novartis AG Recent Developments

11.8 Abbvie

11.8.1 Abbvie Company Details

11.8.2 Abbvie Business Overview

11.8.3 Abbvie Epilepsy Drugs Introduction

11.8.4 Abbvie Revenue in Epilepsy Drugs Business (2017-2022)

11.8.5 Abbvie Recent Developments

11.9 Janssen Pharmaceuticals

11.9.1 Janssen Pharmaceuticals Company Details

11.9.2 Janssen Pharmaceuticals Business Overview

11.9.3 Janssen Pharmaceuticals Epilepsy Drugs Introduction

11.9.4 Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)

11.9.5 Janssen Pharmaceuticals Recent Developments

11.10 Sunovion Pharmaceuticals

11.10.1 Sunovion Pharmaceuticals Company Details

11.10.2 Sunovion Pharmaceuticals Business Overview

11.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Introduction

11.10.4 Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022)

11.10.5 Sunovion Pharmaceuticals Recent Developments

11.11 Bausch Health

11.11.1 Bausch Health Company Details

11.11.2 Bausch Health Business Overview

11.11.3 Bausch Health Epilepsy Drugs Introduction

11.11.4 Bausch Health Revenue in Epilepsy Drugs Business (2017-2022)

11.11.5 Bausch Health Recent Developments

11.12 Sanofi S.A

11.12.1 Sanofi S.A Company Details

11.12.2 Sanofi S.A Business Overview

11.12.3 Sanofi S.A Epilepsy Drugs Introduction

11.12.4 Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022)

11.12.5 Sanofi S.A Recent Developments

11.13 Takeda

11.13.1 Takeda Company Details

11.13.2 Takeda Business Overview

11.13.3 Takeda Epilepsy Drugs Introduction

11.13.4 Takeda Revenue in Epilepsy Drugs Business (2017-2022)

11.13.5 Takeda Recent Developments

11.14 Eisai

11.14.1 Eisai Company Details

11.14.2 Eisai Business Overview

11.14.3 Eisai Epilepsy Drugs Introduction

11.14.4 Eisai Revenue in Epilepsy Drugs Business (2017-2022)

11.14.5 Eisai Recent Developments

11.15 F. Hoffmann-La Roche

11.15.1 F. Hoffmann-La Roche Company Details

11.15.2 F. Hoffmann-La Roche Business Overview

11.15.3 F. Hoffmann-La Roche Epilepsy Drugs Introduction

11.15.4 F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022)

11.15.5 F. Hoffmann-La Roche Recent Developments

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Global Epilepsy Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of First Generation

    Table 3. Key Players of Second Generation

    Table 4. Global Epilepsy Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 5. Global Epilepsy Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Epilepsy Drugs Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Epilepsy Drugs Market Share by Region (2017-2022)

    Table 8. Global Epilepsy Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Epilepsy Drugs Market Share by Region (2023-2028)

    Table 10. Epilepsy Drugs Market Trends

    Table 11. Epilepsy Drugs Market Drivers

    Table 12. Epilepsy Drugs Market Challenges

    Table 13. Epilepsy Drugs Market Restraints

    Table 14. Global Epilepsy Drugs Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Epilepsy Drugs Revenue Share by Players (2017-2022)

    Table 16. Global Top Epilepsy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2021)

    Table 17. Ranking of Global Top Epilepsy Drugs Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Epilepsy Drugs Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Epilepsy Drugs Product Solution and Service

    Table 21. Date of Enter into Epilepsy Drugs Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Epilepsy Drugs Revenue Market Share by Type (2017-2022)

    Table 25. Global Epilepsy Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Epilepsy Drugs Revenue Market Share by Type (2023-2028)

    Table 27. Global Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 28. Global Epilepsy Drugs Revenue Share by Application (2017-2022)

    Table 29. Global Epilepsy Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 30. Global Epilepsy Drugs Revenue Share by Application (2023-2028)

    Table 31. North America Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 32. North America Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)

    Table 33. North America Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 34. North America Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)

    Table 35. North America Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)

    Table 36. North America Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)

    Table 37. Europe Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 38. Europe Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)

    Table 39. Europe Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 40. Europe Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)

    Table 41. Europe Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)

    Table 42. Europe Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)

    Table 43. Asia Pacific Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)

    Table 47. Asia Pacific Epilepsy Drugs Market Size by Region (2017-2022) & (US$ Million)

    Table 48. Asia Pacific Epilepsy Drugs Market Size by Region (2023-2028) & (US$ Million)

    Table 49. Latin America Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 50. Latin America Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)

    Table 51. Latin America Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 52. Latin America Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)

    Table 53. Latin America Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)

    Table 54. Latin America Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)

    Table 55. Middle East and Africa Epilepsy Drugs Market Size by Type (2017-2022) & (US$ Million)

    Table 56. Middle East and Africa Epilepsy Drugs Market Size by Type (2023-2028) & (US$ Million)

    Table 57. Middle East and Africa Epilepsy Drugs Market Size by Application (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Epilepsy Drugs Market Size by Application (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Epilepsy Drugs Market Size by Country (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Epilepsy Drugs Market Size by Country (2023-2028) & (US$ Million)

    Table 61. Abbott Laboratories Company Details

    Table 62. Abbott Laboratories Business Overview

    Table 63. Abbott Laboratories Epilepsy Drugs Product

    Table 64. Abbott Laboratories Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 65. Abbott Laboratories Recent Developments

    Table 66. GlaxoSmithKline Plc Company Details

    Table 67. GlaxoSmithKline Plc Business Overview

    Table 68. GlaxoSmithKline Plc Epilepsy Drugs Product

    Table 69. GlaxoSmithKline Plc Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 70. GlaxoSmithKline Plc Recent Developments

    Table 71. UCB Company Details

    Table 72. UCB Business Overview

    Table 73. UCB Epilepsy Drugs Product

    Table 74. UCB Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 75. UCB Recent Developments

    Table 76. Cephalon Company Details

    Table 77. Cephalon Business Overview

    Table 78. Cephalon Epilepsy Drugs Product

    Table 79. Cephalon Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 80. Cephalon Recent Developments

    Table 81. Johnson & Johnson Company Details

    Table 82. Johnson & Johnson Business Overview

    Table 83. Johnson & Johnson Epilepsy Drugs Product

    Table 84. Johnson & Johnson Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 85. Johnson & Johnson Recent Developments

    Table 86. Pfizer Company Details

    Table 87. Pfizer Business Overview

    Table 88. Pfizer Epilepsy Drugs Product

    Table 89. Pfizer Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 90. Pfizer Recent Developments

    Table 91. Novartis AG Company Details

    Table 92. Novartis AG Business Overview

    Table 93. Novartis AG Epilepsy Drugs Product

    Table 94. Novartis AG Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 95. Novartis AG Recent Developments

    Table 96. Abbvie Company Details

    Table 97. Abbvie Business Overview

    Table 98. Abbvie Epilepsy Drugs Product

    Table 99. Abbvie Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 100. Abbvie Recent Developments

    Table 101. Janssen Pharmaceuticals Company Details

    Table 102. Janssen Pharmaceuticals Business Overview

    Table 103. Janssen Pharmaceuticals Epilepsy Drugs Product

    Table 104. Janssen Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 105. Janssen Pharmaceuticals Recent Developments

    Table 106. Sunovion Pharmaceuticals Company Details

    Table 107. Sunovion Pharmaceuticals Business Overview

    Table 108. Sunovion Pharmaceuticals Epilepsy Drugs Product

    Table 109. Sunovion Pharmaceuticals Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 110. Sunovion Pharmaceuticals Recent Developments

    Table 111. Bausch Health Company Details

    Table 112. Bausch Health Business Overview

    Table 113. Bausch Health Epilepsy Drugs Product

    Table 114. Bausch Health Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 115. Bausch Health Recent Developments

    Table 116. Sanofi S.A Company Details

    Table 117. Sanofi S.A Business Overview

    Table 118. Sanofi S.A Epilepsy Drugs Product

    Table 119. Sanofi S.A Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 120. Sanofi S.A Recent Developments

    Table 121. Takeda Company Details

    Table 122. Takeda Business Overview

    Table 123. Takeda Epilepsy Drugs Product

    Table 124. Takeda Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 125. Takeda Recent Developments

    Table 126. Eisai Company Details

    Table 127. Eisai Business Overview

    Table 128. Eisai Epilepsy Drugs Product

    Table 129. Eisai Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 130. Eisai Recent Developments

    Table 131. F. Hoffmann-La Roche Company Details

    Table 132. F. Hoffmann-La Roche Business Overview

    Table 133. F. Hoffmann-La Roche Epilepsy Drugs Product

    Table 134. F. Hoffmann-La Roche Revenue in Epilepsy Drugs Business (2017-2022) & (US$ Million)

    Table 135. F. Hoffmann-La Roche Recent Developments

    Table 136. Research Programs/Design for This Report

    Table 137. Key Data Information from Secondary Sources

    Table 138. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Epilepsy Drugs Market Share by Type: 2021 VS 2028

    Figure 2. First Generation Features

    Figure 3. Second Generation Features

    Figure 4. Global Epilepsy Drugs Market Share by Application: 2021 VS 2028

    Figure 5. Hospital Pharmacies Case Studies

    Figure 6. Retail Pharmacies Case Studies

    Figure 7. Online Pharmacies Case Studies

    Figure 8. Epilepsy Drugs Report Years Considered

    Figure 9. Global Epilepsy Drugs Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 10. Global Epilepsy Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Epilepsy Drugs Market Share by Region: 2021 VS 2028

    Figure 12. Global Epilepsy Drugs Market Share by Players in 2021

    Figure 13. Global Top Epilepsy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2021)

    Figure 14. The Top 10 and 5 Players Market Share by Epilepsy Drugs Revenue in 2021

    Figure 15. North America Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)

    Figure 16. North America Epilepsy Drugs Market Size Market Share by Type (2017-2028)

    Figure 17. North America Epilepsy Drugs Market Size Market Share by Application (2017-2028)

    Figure 18. North America Epilepsy Drugs Market Size Share by Country (2017-2028)

    Figure 19. United States Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Canada Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)

    Figure 22. Europe Epilepsy Drugs Market Size Market Share by Type (2017-2028)

    Figure 23. Europe Epilepsy Drugs Market Size Market Share by Application (2017-2028)

    Figure 24. Europe Epilepsy Drugs Market Size Share by Country (2017-2028)

    Figure 25. Germany Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. France Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. U.K. Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Italy Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Russia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 30. Nordic Countries Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Asia-Pacific Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)

    Figure 32. Asia Pacific Epilepsy Drugs Market Size Market Share by Type (2017-2028)

    Figure 33. Asia Pacific Epilepsy Drugs Market Size Market Share by Application (2017-2028)

    Figure 34. Asia Pacific Epilepsy Drugs Market Size Share by Region (2017-2028)

    Figure 35. China Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Japan Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. South Korea Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 38. Southeast Asia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. India Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Australia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Latin America Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)

    Figure 42. Latin America Epilepsy Drugs Market Size Market Share by Type (2017-2028)

    Figure 43. Latin America Epilepsy Drugs Market Size Market Share by Application (2017-2028)

    Figure 44. Latin America Epilepsy Drugs Market Size Share by Country (2017-2028)

    Figure 45. Mexico Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 46. Brazil Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 47. Middle East & Africa Epilepsy Drugs Market Size YoY (2017-2028) & (US$ Million)

    Figure 48. Middle East and Africa Epilepsy Drugs Market Size Market Share by Type (2017-2028)

    Figure 49. Middle East and Africa Epilepsy Drugs Market Size Market Share by Application (2017-2028)

    Figure 50. Middle East and Africa Epilepsy Drugs Market Size Share by Country (2017-2028)

    Figure 51. Turkey Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 52. Saudi Arabia Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 53. UAE Epilepsy Drugs Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 54. Abbott Laboratories Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 55. GlaxoSmithKline Plc Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 56. UCB Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 57. Cephalon Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 58. Johnson & Johnson Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 59. Pfizer Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 60. Novartis AG Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 61. Abbvie Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 62. Janssen Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 63. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 64. Bausch Health Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 65. Sanofi S.A Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 66. Takeda Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 67. Eisai Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 68. F. Hoffmann-La Roche Revenue Growth Rate in Epilepsy Drugs Business (2017-2022)

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed